Company / Capital Expenditures
Vericel Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$27.2M
FY2025
5-year range
$2.6M / $64.0M
FY2021-FY2025
Trend
-57.5%
vs FY2024
Sector context
#38 of 194
Health Care
What the data says
Vericel's capital expenditures of $27M is higher than 80% of companies in the Health Care sector (FY2025). Capital Expenditures has fluctuated over the past 10 years, ranging from $829,000 in FY2016 to $64M in FY2024.
Based on SEC 10-K filings.
$27M in FY2025 with a 5-year CAGR of +58.9%. Top quartile in the Health Care sector.
Improved from $20M to $27M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +117.9%
- 5-Year CAGR
- +58.9%
- 10-Year CAGR
- -
Sector benchmark
-76.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +58.9%, indicating consistent growth.
- In FY2025, capital expenditures decreased 57.5% year-over-year.
- Ranks #38 out of 194 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.2M | -57.5% |
| FY2024 | $64.0M | +219.7% |
| FY2023 | $20.0M | +662.1% |
| FY2022 | $2.6M | +0.4% |
| FY2021 | $2.6M | -2.3% |
| FY2020 | $2.7M | +77.4% |
| FY2019 | $1.5M | +6.7% |
| FY2018 | $1.4M | -41.7% |
| FY2017 | $2.4M | +192.8% |
| FY2016 | $829.0K | +1972.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026